Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$37.26 - $67.74 $16 Million - $29.2 Million
-430,616 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$45.01 - $65.47 $2.5 Million - $3.64 Million
55,616 Added 14.83%
430,616 $25.6 Million
Q3 2020

Nov 13, 2020

BUY
$35.79 - $48.81 $13.4 Million - $18.3 Million
375,000 New
375,000 $18 Million
Q1 2020

May 15, 2020

SELL
$16.96 - $34.16 $1.33 Million - $2.67 Million
-78,223 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$24.56 - $32.8 $1.92 Million - $2.57 Million
78,223 New
78,223 $2.34 Million
Q3 2019

Nov 14, 2019

SELL
$30.31 - $53.51 $1.59 Million - $2.81 Million
-52,500 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$40.3 - $48.3 $2.12 Million - $2.54 Million
52,500 New
52,500 $2.51 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $913M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.